Drugs That Carry Risk of Clinical Hemolysis in Persons with G6PD Deficiency

	DEFINITE RISK	POSSIBLE RISK	DOUBTFUL RISK
Drugs That Carry Risk of Clinical Hemolysis in Persons with G6PD Deficiency
Antimalarials	Primaquine Dapsone/chlorproguanil^a	Chloroquine	Quinine
Sulphonamides/sulphones	Sulfamethoxazole Others Dapsone	Sulfasalazine Sulfadimidine	Sulfisoxazole Sulfadiazine
Antibacterial/antibiotics	Cotrimoxazole Nalidixic acid Nitrofurantoin Niridazole	Ciprofloxacin Norfloxacin	Chloramphenicol p-Aminosalicylic acid
Antipyretic/analgesics	Acetanilide Phenazopyridine	Acetylsalicylic acid high dose (>3 g/d)	Acetylsalicylic acid (<3 g/d) Acetaminophen Phenacetin
Other	Naphthalene Methylene blue	Vitamin K analogues Ascorbic acid >1 g Rasburicase	Doxorubicin Probenecid

^a Marketed as Lapdap from 2003 to 2008.